Myocardial remodeling in low-renin hypertension: Molecular pathways to cellular injury in relative aldosteronism

Current Hypertension Reports

Volumn 11, Issue 6, 2009, Pages 412-420

  Weber, Karl T ^a   Bhattacharya, Syamal K ^b   Gandhi, Malay S ^b   Kamalov, German ^b   Ahokas, Robert A ^b   Sun, Yao ^b   Gerling, Ivan C ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALDOSTERONE; AMLODIPINE; CINACALCET; COPPER ZINC SUPEROXIDE DISMUTASE; ISOPRENALINE; PARATHYROID HORMONE; SPIRONOLACTONE; UNCLASSIFIED DRUG; ZINC COMPLEX; ZINC TRANSPORTER; ZINC TRANSPORTER 1;

ALDOSTERONE BLOOD LEVEL; ARTERIAL PRESSURE; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DIET SUPPLEMENTATION; ESSENTIAL HYPERTENSION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERALDOSTERONISM; HYPOCALCEMIA; HYPOMAGNESEMIA; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PARATHYROID HORMONE BLOOD LEVEL; PLASMA RENIN ACTIVITY; PROGNOSIS; REPERFUSION INJURY; REVIEW; SECONDARY HYPERPARATHYROIDISM;

ANIMALS; CALCIUM; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; HUMANS; HYPERALDOSTERONISM; HYPERPARATHYROIDISM, SECONDARY; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAGNESIUM; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING; ZINC;

EID: 72549102503     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0071-0     Document Type: Review

References (69)

1. S. Julius Y. Li D. Brant, et al. 1991 Quinapril, an angiotensin converting enzyme inhibitor, prevents cardiac hypertrophy during episodic hypertension Hypertension 17 1161 1166 1:CAS:528:DyaK3MXksVWltLg%3D 1828458
2. F.H. Messerli T. Grodzicki 1992 Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death Eur Heart J 13 SupplD 66 69 1396863
3. L.M. Shapiro W.J. McKenna 1984 Left ventricular hypertrophy: relation of structure to diastolic function in hypertension Br Heart J 51 637 642 10.1136/hrt.51.6.637 1:STN:280:DyaL2c3jtFymsQ%3D%3D 6234010
4. N. Sugihara A. Genda M. Shimizu, et al. 1988 Diastolic dysfunction and its relation to myocardial fibrosis in essential hypertension J Cardiol 18 353 361 1:STN:280:DyaL1M3lvVamtg%3D%3D 2977793
5. J. Díez R. Querejeta B. López, et al. 2002 Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients Circulation 105 2512 2517 10.1161/01.CIR.0000017264.66561.3D 12034658 (Pubitemid 34568973)
6. J.K. Ghali S. Kadakia R.S. Cooper Y. Liao 1991 Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease J Am Coll Cardiol 17 1277 1282 1:STN:280:DyaK3M3gtFKnug%3D%3D 1826691
7. R.S. Cooper B.E. Simmons A. Castaner, et al. 1990 Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed Am J Cardiol 65 441 445 10.1016/0002-9149(90)90807-D 1:STN:280:DyaK3c7msVCisg%3D%3D 2137665 (Pubitemid 20050523)
8. E.S. Pearlman K.T. Weber J.S. Janicki, et al. 1982 Muscle fiber orientation and connective tissue content in the hypertrophied human heart Lab Invest 46 158 164 1:STN:280:DyaL387ks12nsA%3D%3D 6460896
9. J.A.N. Huysman H.W. Vliegen A. Van der Laarse F. Eulderink 1989 Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophic human hearts Pathol Res Pract 184 577 581 1:STN:280: DyaL1Mzos1ejtw%3D%3D 2528728
10. M.A. Rossi 1998 Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans J Hypertens 16 1031 1041 10.1097/00004872-199816070-00018 1:STN:280: DyaK1M%2FgvVyktA%3D%3D 9794745 (Pubitemid 28367959)
11. Cooper RS, Ghali JK: Coronary heart disease: blackwhite differences. In Cardiovascular Diseases in Blacks. Edited by Saunders E. Philadelphia: F. A. Davis; 1991:205-225.
12. J.K. Ghali S. Kadakia R. Cooper J. Ferlinz 1988 Precipitating factors leading to decompensation of heart failure. Traits among urban blacks Arch Intern Med 148 2013 2016 10.1001/archinte.148.9.2013 1:STN:280: DyaL1czisFOmtA%3D%3D 3046541 (Pubitemid 18211041)
13. H.R. Brunner J.H. Laragh L. Baer, et al. 1972 Essential hypertension: renin and aldosterone, heart attack and stroke N Engl J Med 286 441 449 1:STN:280:DyaE38%2FpvVSqsQ%3D%3D 4257928
14. G.H. Williams J.P. Cain R.G. Dluhy R.H. Underwood 1972 Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading J Clin Invest 51 1731 1742 10.1172/JCI106974 1:CAS:528:DyaE38XksF2lt7Y%3D 4338121
15. R.D. Collins M.H. Weinberger A.J. Dowdy, et al. 1970 Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity J Clin Invest 49 1415 1426 10.1172/JCI106359 1:CAS:528:DyaE3cXkslCrsr4%3D 4317384
16. G.H. Williams N.K. Hollenberg 1991 Functional derangements in the regulation of aldosterone secretion in hypertension Hypertension 18 III143 III149 1:STN:280:DyaK38%2FjvF2ntQ%3D%3D 1937678
17. L.M. Resnick F.B. Müller J.H. Laragh 1986 Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism Ann Intern Med 105 649 654 1:CAS:528:DyaL2sXkvVSiug%3D%3D 3532893
18. E. Rossi C. Sani F. Perazzoli, et al. 1995 Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas Am J Hypertens 8 884 893 10.1016/0895-7061(95)00182-O 1:CAS:528:DyaK2MXoslGrt7s%3D 8541003
19. N.H. Bell A. Greene S. Epstein, et al. 1985 Evidence for alteration of the vitamin D-endocrine system in blacks J Clin Invest 76 470 473 10.1172/JCI111995 1:CAS:528:DyaL2MXltlGqu74%3D 3839801 (Pubitemid 15227507)
20. B.P. Sawaya M.C. Monier-Faugere P. Ratanapanichkich, et al. 2002 Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism Clin Nephrol 57 51 55 1:CAS:528:DC%2BD38Xht1ylu7Y%3D 11837801
21. S. Alsafwah S.P. LaGuardia M.D. Nelson, et al. 2008 Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure Am J Med Sci 335 292 297 10.1097/MAJ.0b013e318167b0bd 18414068 (Pubitemid 351548648)
22. R. Horton E.G. Biglieri 1962 Effect of aldosterone on the metabolism of magnesium J Clin Endocrinol Metab 22 1187 1192 10.1210/jcem-22-12-1187 1:CAS:528:DyaF3sXnsFKqtw%3D%3D 13964048
23. J.W. Conn 1963 Aldosteronism in man. Some clinical and climatological aspects. Part II JAMA 183 871 878 1:CAS:528:DyaF3sXkt12ku7s%3D 14022604
24. J.L. Garcia Zozaya M. Padilla Viloria 1997 [Alterations of calcium, magnesium, and zinc in essential hypertension: their relation to the renin-angiotensin-aldosterone system] [Spanish] Invest Clin 38 Suppl2 27 40 9471228
25. S. Tubek 2005 Zinc content in lymphocytes and the activity of zinc ion efflux from lymphocytes in primary arterial hypertension Biol Trace Elem Res 107 89 99 10.1385/BTER:107:2:089 1:CAS:528:DC%2BD2MXhtFGkt7nO 16217134
26. A.J. Cohen F.J. Roe 2000 Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt Food Chem Toxicol 38 237 253 10.1016/S0278-6915(99)00145-3 1:CAS:528:DC%2BD3cXhslamsrw%3D 10717363 (Pubitemid 30136274)
27. A. Fleckenstein 1967 [Metabolic problems in myocardium insufficiency] [German] Verh Dtsch Ges Pathol 51 15 30 1:STN:280:DyaF1czmvFSguw%3D%3D 4174681
28. T. Fujita G.M. Palmieri 2000 Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload J Bone Miner Metab 18 109 125 10.1007/s007740050101 1:CAS:528:DC%2BD3cXkslylsLg%3D 10783844
29. S.G. Massry M. Smogorzewski 1994 Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia Semin Nephrol 14 219 231 1:STN:280:DyaK2czhtVaqsw%3D%3D 8036356
30. M. Smogorzewski M. Zayed Y.B. Zhang, et al. 1993 Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes Am J Physiol 264 H1998 H2006 1:CAS:528:DyaK3sXlslCmsb4%3D 8322930
31. D. Rampe A.E. Lacerda R.C. Dage A.M. Brown 1991 Parathyroid hormone: an endogenous modulator of cardiac calcium channels Am J Physiol 261 6Pt2 H1945 H1950 1:CAS:528:DyaK38Xns1ygsQ%3D%3D 1661094
32. I. Tastan R. Schreckenberg S. Mufti, et al. 2009 Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a nonacute way Cardiovasc Res 82 77 83 10.1093/cvr/cvp027 1:CAS:528:DC%2BD1MXjt1Clsb8%3D 19168854
33. A. Virdis M.F. Neves F. Amiri, et al. 2002 Spironolactone improves angiotensin-induced vascular changes and oxidative stress Hypertension 40 504 510 10.1161/01.HYP.0000034738.79310.06 1:CAS:528:DC%2BD38Xntlams7Y%3D 12364354
34. Q. Pu M.F. Neves A. Virdis, et al. 2003 Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling Hypertension 42 49 55 10.1161/01.HYP.0000078357.92682.EC 1:CAS:528:DC%2BD3sXkvVKmtrk%3D 12782645 (Pubitemid 36849598)
35. Y. Sun J. Zhang L. Lu, et al. 2002 Aldosterone-induced inflammation in the rat heart. Role of oxidative stress Am J Pathol 161 1773 1781 1:CAS:528:DC%2BD38XptV2gtLk%3D 12414524
36. I.C. Gerling Y. Sun R.A. Ahokas, et al. 2003 Aldosteronism: an immunostimulatory state precedes the proinflammatory/fibrogenic cardiac phenotype Am J Physiol Heart Circ Physiol 285 H813 H821 1:CAS:528: DC%2BD3sXmsVagsbg%3D 12860567
37. D.A. McCarron P.A. Pingree R.J. Rubin, et al. 1980 Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak Hypertension 2 162 168 1:STN:280:DyaL3c3gtlegtQ%3D%3D 7380520
38. A.U. Klingbeil M. Schneider P. Martus, et al. 2003 A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension Am J Med 115 41 46 10.1016/S0002-9343(03)00158-X 12867233 (Pubitemid 36831120)
39. P.M. Okin R.B. Devereux K.E. Harris, et al. 2007 Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients Ann Intern Med 147 311 319 17785486
40. P.M. Okin R.B. Devereux S. Jern, et al. 2004 Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events JAMA 292 2343 2349 10.1001/jama.292.19.2343 1:CAS:528:DC%2BD2cXhtVSmt7vM 15547161 (Pubitemid 39491918)
41. S. Julius M.H. Alderman G. Beevers, et al. 2004 Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study J Am Coll Cardiol 43 1047 1055 10.1016/j.jacc.2003.11.029 15028365 (Pubitemid 38352987)
42. C.G. Brilla R. Pick L.B. Tan, et al. 1990 Remodeling of the rat right and left ventricle in experimental hypertension Circ Res 67 1355 1364 1:STN:280:DyaK3M%2FlvFCmug%3D%3D 1700933
43. Y. Sun F.J.A. Ramires K.T. Weber 1997 Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion Cardiovasc Res 35 138 147 10.1016/S0008-6363(97)00097-7 1:CAS:528:DyaK2sXlvFejt7Y%3D 9302358 (Pubitemid 27374751)
44. E.L. Schiffrin 1995 Endothelin: potential role in hypertension and vascular hypertrophy Hypertension 25 1135 1143 1:CAS:528:DyaK2MXmvVChurc%3D 7768553
45. K.T. Weber 2001 Aldosterone in congestive heart failure N Engl J Med 345 1689 1697 10.1056/NEJMra000050 1:CAS:528:DC%2BD3MXovFKjtbw%3D 11759649 (Pubitemid 33126826)
46. M. Young M. Fullerton R. Dilley J. Funder 1994 Mineralocorticoids, hypertension, and cardiac fibrosis J Clin Invest 93 2578 2583 10.1172/JCI117269 1:CAS:528:DyaK2cXlsFClsbs%3D 8200995
47. A. Garnier J.K. Bendall S. Fuchs, et al. 2004 Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice Circulation 110 1819 1825 10.1161/01.CIR.0000142858. 44680.27 1:CAS:528:DC%2BD2cXnslems70%3D 15364804 (Pubitemid 39299224)
48. M.J. Somers K. Mavromatis Z.S. Galis D.G. Harrison 2000 Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt Circulation 101 1722 1728 1:CAS:528: DC%2BD3cXjtF2ntr0%3D 10758056
49. M.S. Gandhi P.A. Deshmukh G. Kamalov, et al. 2008 Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism J Cardiovasc Pharmacol 52 245 252 10.1097/FJC.0b013e3181833eb8 1:CAS:528:DC%2BD1cXhtFers73K 18806605
50. A. Fleckenstein M. Frey G. Fleckenstein-Grun 1983 Consequences of uncontrolled calcium entry and its prevention with calcium antagonists Eur Heart J 4 SupplH 43 50 1:CAS:528:DyaL2cXpsF2iug%3D%3D 6662132
51. V.S. Chhokar Y. Sun S.K. Bhattacharya, et al. 2005 Hyperparathyroidism and the calcium paradox of aldosteronism Circulation 111 871 878 10.1161/01.CIR.0000155621.10213.06 1:CAS:528:DC%2BD2MXhtlait7Y%3D 15710759 (Pubitemid 40279888)
52. R.A. Ahokas Y. Sun S.K. Bhattacharya, et al. 2005 Aldosteronism and a proinflammatory vascular phenotype. Role of Mg2+, Ca2+ and H2O2 in peripheral blood mononuclear cells Circulation 111 51 57 10.1161/01.CIR.0000151516.84238.37 1:CAS:528:DC%2BD2cXhtFeisLrK 15611366 (Pubitemid 40070843)
53. R.A. Ahokas K.J. Warrington I.C. Gerling, et al. 2003 Aldosteronism and peripheral blood mononuclear cell activation. A neuro endocrine-immune interface Circ Res 93 e124 e135 10.1161/01.RES.0000102404.81461.25 1:CAS:528: DC%2BD3sXoslyku7w%3D 14576195
54. V.S. Chhokar Y. Sun S.K. Bhattacharya, et al. 2004 Loss of bone minerals and strength in rats with aldosteronism Am J Physiol Heart Circ Physiol 287 H2023 H2026 10.1152/ajpheart.00477.2004 1:CAS:528:DC%2BD2cXhtVaqtr%2FF 15475529 (Pubitemid 39430739)
55. D.A. McCarron C.D. Morris R. Bukoski 1987 The calcium paradox of essential hypertension Am J Med 82 27 33 10.1016/0002-9343(87)90268-3 1:CAS:528:DyaL2sXhsFeqtb0%3D 3544831
56. K.D. Goodwin R.A. Ahokas S.K. Bhattacharya, et al. 2006 Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements Am J Med Sci 332 73 78 10.1097/00000441-200608000- 00004 16909053 (Pubitemid 44243862)
57. A. Vidal Y. Sun S.K. Bhattacharya, et al. 2006 Calcium paradox of aldosteronism and the role of the parathyroid glands Am J Physiol Heart Circ Physiol 290 H286 H294 10.1152/ajpheart.00535.2005 1:CAS:528:DC%2BD28XhsVKju7o%3D 16373592
58. Y. Selektor R.A. Ahokas S.K. Bhattacharya, et al. 2008 Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism Am J Med Sci 335 105 110 10.1097/MAJ.0b013e318134f013 18277117 (Pubitemid 351253405)
59. M. Thomas A. Vidal S.K. Bhattacharya, et al. 2007 Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone Am J Physiol Heart Circ Physiol 293 H2361 H2366 10.1152/ajpheart.00200.2007 1:CAS:528:DC%2BD2sXht1WlurfM 17616752 (Pubitemid 47605882)
60. Y. Selektor R.B. Parker Y. Sun, et al. 2008 Tissue 65Zinc translocation in a rat model of chronic aldosteronism J Cardiovasc Pharmacol 51 359 364 10.1097/FJC.0b013e318165b96e 1:CAS:528:DC%2BD1cXltVWgu74%3D 18427278 (Pubitemid 351572234)
61. L. Aureli M. Gioia I. Cerbara, et al. 2008 Structural bases for substrate and inhibitor recognition by matrix metalloproteinases Curr Med Chem 15 2192 2222 10.2174/092986708785747490 1:CAS:528:DC%2BD1MXisFCksbg%3D 18781944
62. G. Kamalov P.A. Deshmukh N.Y. Baburyan, et al. 2009 Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism J Cardiovasc Pharmacol 53 414 423 10.1097/FJC.0b013e3181a15e77 1:CAS:528:DC%2BD1MXmtVOns7s%3D 19333130
63. J. Wang Y. Song L. Elsherif, et al. 2006 Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation Circulation 113 544 554 10.1161/CIRCULATIONAHA.105.537894 1:CAS:528:DC%2BD28XmvVSgsQ%3D%3D 16432057 (Pubitemid 43754355)
64. G. Karagulova Y. Yue A. Moreyra, et al. 2007 Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms J Pharmacol Exp Ther 321 517 525 10.1124/jpet.107.119644 1:CAS:528:DC%2BD2sXltFehtLc%3D 17322024 (Pubitemid 46624490)
65. M. Chvapil J.A. Owen 1977 Effect of zinc on acute and chronic isoproterenol induced heart injury J Mol Cell Cardiol 9 151 159 10.1016/0022-2828(77)90046-3 1:CAS:528:DyaE2sXhtVWjsLo%3D 839549 (Pubitemid 8024772)
66. G.M. Palmieri D.F. Nutting S.K. Bhattacharya, et al. 1981 Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris J Clin Invest 68 646 654 10.1172/JCI110299 1:CAS:528:DyaL3MXls1Klsbk%3D 7276164
67. S.K. Bhattacharya G.M. Palmieri T.E. Bertorini D.F. Nutting 1982 The effects of diltiazem in dystrophic hamsters Muscle Nerve 5 73 78 10.1002/mus.880050114 1:CAS:528:DyaL38XhslChsLs%3D 7057811
68. A.J. Crawford S.K. Bhattacharya 1987 Excessive intracellular zinc accumulation in cardiac and skeletal muscles of dystrophic hamsters Exp Neurol 95 265 276 10.1016/0014-4886(87)90137-3 1:CAS:528:DyaL2sXhtlKgur0%3D 3803514 (Pubitemid 17017926)
69. J. Díez 2009 Towards a new paradigm about hypertensive heart disease Med Clin North Am 93 637 645 10.1016/j.mcna.2009.02.002 19427496